SGLT-2 inhibitors to become first-choice treatments for type 2 diabetes

Draft NICE guidelines propose upgrading Sodium-Glucose Transport Protein 2 (SGLT-2) inhibitors from second choice to first-choice treatments for type 2 diabetes.

The updated draft guideline, ‘Type 2 diabetes in adults: management (medicines update) NG28’, opened for consultation this week.

Read more
 

Teplizumab authorised by the MHRA

The first ever immunotherapy for type 1 diabetes has now been licensed for use in the UK.

The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed teplizumab, also known as Tzield, is safe and effective at delaying the development of type 1 diabetes for people in the early stages of the condition.

 
Read more
 

Mounjaro demonstrated cardiovascular protection in landmark trial

Eli Lilly and Company has announced  results from a Phase 3 cardiovascular outcomes trial comparing two incretin therapies in adults with type 2 diabetes and atherosclerotic cardiovascular disease. To read more, click here.

Lilly and UK Government announce obesity pathway innovation programme for up to £85 million

Eli Lilly and Company and the UK Government Department for Science, Innovation and Technology (DSIT) have announced a programme to develop innovative models of care for obesity. To read more, click here. 

 

Diabetes technology and HCL scoping document to be launched

A new scoping document designed to help healthcare professionals assess their knowledge and skills in diabetes technologies and hybrid closed-loop (HCL) systems will soon be launched.

Developed by the Leicester Diabetes Centre, this four-tier competency framework sets out clear criteria to identify the knowledge and skills each healthcare professional should possess depending on their role and service requirements.

Read more
 

Discontinuation of Levemir® (insulin detemir)

Levemir® insulin, both Penfill® and Flexpen® , is to be discontinued, with an end date of December 2026. To read more, click here.

Trividia Health UK  partners with Well Pharmacy

A leading blood glucose testing company has launched a range of products with Well Pharmacy. To read more, click here. 

 

User feedback required about new CamAPS FX app feature

A study to find out people’s thoughts about the new app feature of CamAPS FX has been launched by CamDiab. To read more, click here.

Wockhardt’s Hypurin Porcine 10ml insulin vials to be discontinued

A Medicine Supply Notification has been issued about the discontinuation of Wockhardt’s Hypurin Porcine insulin in 10ml vials. To read more, click here. 

 

First-of-its-kind research reveals scale of stigma facing people with diabetes in the UK

New data has revealed the worrying levels of stigma and judgment people with diabetes are facing across the UK. To read more, click here.

Nearly a fifth of Brits cannot identify a single risk factor of type 2 diabetes

Tesco and Diabetes UK are urging the nation to learn about type 2 diabetes, after research uncovered a lack of awareness. To read more, click here. 

 
 
 

Bringing you the latest jobs from around the country within the field of diabetes.

Diabetes Specialist Nurse – Manchester University NHS Foundation Trust

Band 8C Nurse Consultant Diabetes​​​​​​ – Royal Free London NHS Foundation Trust

Diabetes Dietitian – Chesterfield Royal Hospital NHS Foundation Trust

Specialist Dietitian for Diabetes​​​​​​​ – The Mid Yorkshire Teaching NHS Trust​​​​​​​

 

Join the expanding diabetes community on X and follow us for the latest diabetes news updates at @DiabetesTimes.

We are now on YouTube where you will find interviews with leading figures within the field of diabetes. Click here to visit our page. 

 
FacebookTwitterWebsite
 
  Share 
  Tweet 
  Share 
  Forward 

The Diabetes Times

Harborough Enterprise Centre

Suite 105

Compass Point Business Park

Northampton Rd

Market Harborough

LE16 9HW

Preferences  |  Unsubscribe